Tech Company Financing Transactions
Bioxtreme Funding Round
Bioxtreme, operating out of Petach Tikva, secured funding from Serra Ventures and private investors.
Transaction Overview
Company Name
Announced On
4/23/2026
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Serra Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds for global expansion, strengthening operations in the United States and Europe, and supporting the launch of Plaxtreme.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7 Imber St.
Petach Tikva, 4951141
Israel
Petach Tikva, 4951141
Israel
Phone
Undisclosed
Website
Email Address
Overview
Bioxtreme is developing robotics rehabilitation systems for stroke, TBI and other neurological disorders, based on Error Enhancement technology (Bioxtreme's patent). The system is expected to save 50% on the rehabilitation treatment time, and to offer the first cost-effective solution in the market. At last, patients recovering from stroke and neurological disorders, can gain effective therapy, while hospitals and healthcare system can make dramatic savings on the rehabilitation cost.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eyal Shachar
VP - Product Management
Oded Lazarovich
Browse more venture capital transactions:
Prev: 4/22/2026: ATMOS Space Cargo venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs